Published in J Virol on August 01, 1999
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science (2008) 1.97
CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol (2005) 1.26
Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol (2011) 1.23
CD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection. J Virol (2001) 1.22
Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. Proc Natl Acad Sci U S A (2004) 1.20
Effects of type I interferons on Friend retrovirus infection. J Virol (2006) 1.14
The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control. J Virol (2007) 1.10
B lymphocyte activation by coinfection prevents immune control of friend virus infection. J Immunol (2008) 1.06
Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection. J Virol (2009) 1.05
Effects of acute and chronic murine norovirus infections on immune responses and recovery from Friend retrovirus infection. J Virol (2009) 1.04
Tissue-specific abundance of regulatory T cells correlates with CD8+ T cell dysfunction and chronic retrovirus loads. J Immunol (2009) 1.04
Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. J Virol (2010) 1.04
Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. J Virol (2002) 1.01
Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection. J Virol (2001) 1.01
Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo. J Immunol (2014) 0.90
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model. Retrovirology (2011) 0.89
Replication of beta- and gammaretroviruses is restricted in I/LnJ mice via the same genetic mechanism. J Virol (2007) 0.88
Negative impact of IFN-γ on early host immune responses to retroviral infection. J Immunol (2012) 0.85
Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs. PLoS Pathog (2010) 0.84
Mice of the resistant H-2(b) haplotype mount broad CD4(+) T cell responses against 9 distinct Friend virus epitopes. Virology (2014) 0.82
Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. Sci Rep (2016) 0.80
Retroviral immunology: lessons from a mouse model. Immunol Res (2009) 0.78
Vital role for CD8+ cells in controlling retroviral infections. J Virol (2011) 0.77
In vitro and in vivo analyses of regulatory T cell suppression of CD8+ T cells. Methods Mol Biol (2011) 0.75
Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads. PLoS Negl Trop Dis (2016) 0.75
B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection. MBio (2017) 0.75
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature (1985) 9.62
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J Natl Cancer Inst (1970) 6.08
Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (1990) 4.59
A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell (1990) 4.23
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
The effect of histocompatibility-2 type on response to friend leukemia virus in mice. J Exp Med (1968) 2.57
Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science (1993) 2.20
Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell (1991) 2.16
T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Science (1986) 2.06
Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J Virol Methods (1991) 2.01
Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc Natl Acad Sci U S A (1979) 1.95
Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J (1993) 1.86
Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice. J Virol (1998) 1.83
Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection. Annu Rev Immunol (1990) 1.83
Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly. J Immunol (1978) 1.66
The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene (1989) 1.65
Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol Cell Biol (1990) 1.58
The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol (1991) 1.58
Fv-2 locus controls the proportion of erythropoietic progenitor cells (BFU-E) synthesizing DNA in normal mice. Cell (1980) 1.57
Different H-2 subregions influence immunization against retrovirus and immunosuppression. Nature (1987) 1.43
Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol Cell Biol (1992) 1.41
Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms. J Virol (1998) 1.39
Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia. J Immunol (1983) 1.38
Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol Cell Biol (1993) 1.38
Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol (1993) 1.36
Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness. Proc Natl Acad Sci U S A (1995) 1.33
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A (1990) 1.33
Spi-1 oncogene activation in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia (1990) 1.15
Immunoprotective determinants in friend murine leukemia virus envelope protein. Virology (1998) 1.14
Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol (1995) 1.13
Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development. J Immunol (1995) 1.13
Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J Biol Chem (1993) 1.07
Differing T-cell requirements for recombinant retrovirus vaccines. J Virol (1996) 1.02
Induction of protective immunity to Friend murine leukemia virus in genetic nonresponders to virus envelope protein. J Immunol (1991) 1.01
Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses. J Virol (1993) 0.98
Friend virus replication in normal and immunosuppressed C57BL/6 mice. Virology (1990) 0.97
Mutations in the env gene of friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia. J Virol (1992) 0.95
Friend leukemia as a multiple-step disease. Blood Cells (1981) 0.93
Cellular site and mode of Fv-2 gene action. Cell (1985) 0.93
Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype. Proc Natl Acad Sci U S A (1991) 0.92
p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene (1991) 0.91
Spontaneous recovery from Friend retrovirus-induced leukemia. Mapping of the Rfv-2 gene in the Q/TL region of mouse MHC. J Immunol (1992) 0.90
Friend virus induced murine erythroleukaemia: the p53 locus. Cancer Surv (1992) 0.90
Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia. Cancer Res (1986) 0.88
Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia. J Virol (1994) 0.87
Expression of resistance to Friend virus-stimulated erythropoiesis in bone marrow chimeras containing Fv-2rr and Fv-2ss bone marrow. J Exp Med (1981) 0.86
Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice. J Virol (1998) 0.84
Infection and transformation of Fv-2rr erythroprogenitor cells with Friend virus. Virus Res (1987) 0.81